Sergliflozin etabonate
Sergliflozin etabonate (GW-869682X) is a potent and orally active sodium glucose cotransporter (SGLT2) inhibitor. Sergliflozin etabonate shows antidiabetic and antihyperglycemic effects. Sergliflozin etabonate significantly reduces non-fasting blood glucose levels in diabetic mice. Sergliflozin etabonate has the potential for the research of diabetes[1].
Product Specifications
CAS Number
[408504-26-7]
Product Name Alternative
GW-869682X
UNSPSC
12352005
Target
SGLT
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/sergliflozin-etabonate.html
Concentration
10mM
Purity
99.64
Solubility
DMSO : ≥ 100 mg/mL
Smiles
COC(C=C1)=CC=C1CC(C=CC=C2)=C2O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)COC(OCC)=O
Molecular Formula
C23H28O9
Molecular Weight
448.46
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SGLT2
Available Sizes
Explore Other Products
Browse additional items from our catalog
MN1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)